Cargando…
Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132742/ https://www.ncbi.nlm.nih.gov/pubmed/34009544 http://dx.doi.org/10.1007/s10875-021-01060-0 |
| _version_ | 1783694947460841472 |
|---|---|
| author | Vazquez, Sara E. Bastard, Paul Kelly, Kathleen Gervais, Adrian Norris, Philip J. Dumont, Larry J. Casanova, Jean-Laurent Anderson, Mark S. DeRisi, Joseph L. |
| author_facet | Vazquez, Sara E. Bastard, Paul Kelly, Kathleen Gervais, Adrian Norris, Philip J. Dumont, Larry J. Casanova, Jean-Laurent Anderson, Mark S. DeRisi, Joseph L. |
| author_sort | Vazquez, Sara E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8132742 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81327422021-05-19 Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma Vazquez, Sara E. Bastard, Paul Kelly, Kathleen Gervais, Adrian Norris, Philip J. Dumont, Larry J. Casanova, Jean-Laurent Anderson, Mark S. DeRisi, Joseph L. J Clin Immunol Letter to Editor Springer US 2021-05-19 2021 /pmc/articles/PMC8132742/ /pubmed/34009544 http://dx.doi.org/10.1007/s10875-021-01060-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to Editor Vazquez, Sara E. Bastard, Paul Kelly, Kathleen Gervais, Adrian Norris, Philip J. Dumont, Larry J. Casanova, Jean-Laurent Anderson, Mark S. DeRisi, Joseph L. Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma |
| title | Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma |
| title_full | Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma |
| title_fullStr | Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma |
| title_full_unstemmed | Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma |
| title_short | Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma |
| title_sort | neutralizing autoantibodies to type i interferons in covid-19 convalescent donor plasma |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132742/ https://www.ncbi.nlm.nih.gov/pubmed/34009544 http://dx.doi.org/10.1007/s10875-021-01060-0 |
| work_keys_str_mv | AT vazquezsarae neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT bastardpaul neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT kellykathleen neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT gervaisadrian neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT norrisphilipj neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT dumontlarryj neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT casanovajeanlaurent neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT andersonmarks neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma AT derisijosephl neutralizingautoantibodiestotypeiinterferonsincovid19convalescentdonorplasma |